Defined culture medium for stem cell differentiation: Applicability of serum-free conditions in the mouse embryonic stem cell test

Toxicology in Vitro

Volumn 25, Issue 4, 2011, Pages 914-921

  Riebeling, Christian ^a   Schlechter, Katharina ^a,b   Buesen, Roland ^a,c   Spielmann, Horst ^a,d   Luch, Andreas ^a   Seiler, Andrea ^a  

^a FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^b TECHNISCHE HOCHSCHULE MITTELHESSEN   (Germany)

^c BASF SE   (Germany)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Alternatives to animal testing; Cardiomyocyte differentiation; Embryonic stem cell test; Serum free; Stem cell

Indexed keywords

ACTIVIN A; ASCORBIC ACID; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CELL MARKER; GROWTH FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYONIC STEM CELL TEST; FETAL CALF SERUM; FLOW CYTOMETRY; HEART MUSCLE; HEART MUSCLE CELL; IMMUNOFLUORESCENCE MICROSCOPY; MOUSE; NERVE CELL; NONHUMAN; PROCEDURES CONCERNING CELLS; PROTEIN EXPRESSION; STEM CELL;

ANIMAL TESTING ALTERNATIVES; ANIMALS; BIOLOGICAL MARKERS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NEURONS;

ANIMALIA;

EID: 79955475110     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.02.013     Document Type: Article

References (58)

1. Amit M., Shariki C., Margulets V., Itskovitz-Eldor J. Feeder layer- and serum-free culture of human embryonic stem cells. Biol. Reprod. 2004, 70:837-845.
2. Augustine-Rauch K., Zhang C.X., Panzica-Kelly J.M. In vitro developmental toxicology assays: a review of the state of the science of rodent and zebrafish whole embryo culture and embryonic stem cell assays. Birth Defects Res. C Embryo. Today 2010, 90:87-98.
3. Bader D., Masaki T., Fischman D.A. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 1982, 95:763-770.
4. Balls M., Hellsten E. Statement of the scientific validity of the embryonic stem cell test (EST) - an in vitro test for embryotoxicity. Altern. Lab. Anim. 2002, 30:265-268.
5. Behfar A., Zingman L.V., Hodgson D.M., Rauzier J.M., Kane G.C., Terzic A., Puceat M. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J. 2002, 16:1558-1566.
6. Brown N.A. Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. Altern. Lab. Anim. 2002, 30:177-198.
7. Buesen R., Genschow E., Slawik B., Visan A., Spielmann H., Luch A., Seiler A. Embryonic stem cell test remastered: comparison between the validated EST and the new molecular FACS-EST for assessing developmental toxicity in vitro. Toxicol. Sci. 2009, 108:389-400.
8. Campbell K., Götz M. Radial glia: multi-purpose cells for vertebrate brain development. Trends Neurosci. 2002, 25:235-238.
9. Chaudhry M.A., Vitalis T.Z., Bowen B.D., Piret J.M. Basal medium composition and serum or serum replacement concentration influences on the maintenance of murine embryonic stem cells. Cytotechnology 2008, 58:173-179.
10. Chien C.L., Liem R.K. Characterization of the mouse gene encoding the neuronal intermediate filament protein alpha-internexin. Gene 1994, 149:289-292.
11. Coecke S., Balls M., Bowe G., Davis J., Gstraunthaler G., Hartung T., Hay R., Merten O.W., Price A., Schechtman L., Stacey G., Stokes W. Guidance on good cell culture practice. A report of the second ECVAM task force on good cell culture practice. Altern. Lab. Anim. 2005, 33:261-287.
12. Doetschman T.C., Eistetter H., Katz M., Schmidt W., Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 1985, 87:27-45.
13. European Centre for the Validation of Alternative Methods Scientific Advisory Committee, 2008. ESAC statement on the use of FCS and other animal-derived supplements. In: http://www.ecvam.jrc.it/publication/ESAC28_statement_FCS_20080508.pdf.
14. Garcia-Gonzalo F.R., Izpisua Belmonte J.C. Albumin-associated lipids regulate human embryonic stem cell self-renewal. PLoS. One 2008, 3:e1384.
15. Genschow E., Spielmann H., Scholz G., Pohl I., Seiler A., Clemann N., Bremer S., Becker K. Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern. Lab. Anim. 2004, 32:209-244.
16. Jalava N.S., Lopez-Picon F.R., Kukko-Lukjanov T.K., Holopainen I.E. Changes in microtubule-associated protein-2 (MAP2) expression during development and after status epilepticus in the immature rat hippocampus. Int. J. Dev. Neurosci. 2007, 25:121-131.
17. Jayme D.W., Epstein D.A., Conrad D.R. Fetal bovine serum alternatives. Nature 1988, 334:547-548.
18. Johansson B.M., Wiles M.V. Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development. Mol. Cell Biol. 1995, 15:141-151.
19. Kaplan M.P., Chin S.S., Fliegner K.H., Liem R.K. Alpha-internexin, a novel neuronal intermediate filament protein, precedes the low molecular weight neurofilament protein (NF-L) in the developing rat brain. J. Neurosci. 1990, 10:2735-2748.
20. Kawai T., Takahashi T., Esaki M., Ushikoshi H., Nagano S., Fujiwara H., Kosai K. Efficient cardiomyogenic differentiation of embryonic stem cell by fibroblast growth factor 2 and bone morphogenetic protein 2. Circ. J. 2004, 68:691-702.
21. Lanza R., Gearhart J., Hogan B., Melton D., Pedersen R., Thomas E.D., Thomson J., Wilmut I. Essentials of Stem Cell Biology 2009, Academic Press, London, UK.
22. Li L., Xie T. Stem cell niche: structure and function. Annu. Rev. Cell Dev. Biol. 2005, 21:605-631.
23. Liu L., Geisert E.E., Frankfurter A., Spano A.J., Jiang C.X., Yue J., Dragatsis I., Goldowitz D. A transgenic mouse class-III beta tubulin reporter using yellow fluorescent protein. Genesis 2007, 45:560-569.
24. Mannello F., Tonti G.A. Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold!. Stem Cells 2007, 25:1603-1609.
25. Marx-Stoelting P., Adriaens E., Ahr H.J., Bremer S., Garthoff B., Gelbke H.P., Piersma A., Pellizzer C., Reuter U., Rogiers V., Schenk B., Schwengberg S., Seiler A., Spielmann H., Steemans M., Stedman D.B., Vanparys P., Vericat J.A., Verwei M., van der Water F., Weimer M., Schwarz M. A review of the implementation of the embryonic stem cell test (EST). The report and recommendations of an ECVAM/ReProTect Workshop. Altern. Lab. Anim. 2009, 37:313-328.
26. Maurer H.R. Serum-free media and cell cultures. Introductory remarks. Cytotechnology 1991, 5:1.
27. Melkoumian Z., Weber J.L., Weber D.M., Fadeev A.G., Zhou Y., Dolley-Sonneville P., Yang J., Qiu L., Priest C.A., Shogbon C., Martin A.W., Nelson J., West P., Beltzer J.P., Pal S., Brandenberger R. Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat. Biotechnol. 2010, 28:606-610.
28. Murabe M., Yamauchi J., Fujiwara Y., Hiroyama M., Sanbe A., Tanoue A. A novel embryotoxic estimation method of VPA using ES cells differentiation system. Biochem. Biophys. Res. Commun. 2007, 352:164-169.
29. Murabe M., Yamauchi J., Fujiwara Y., Miyamoto Y., Hiroyama M., Sanbe A., Tanoue A. Estimation of the embryotoxic effect of CBZ using an ES cell differentiation system. Biochem. Biophys. Res. Commun. 2007, 356:739-744.
30. Pachter J.S., Liem R.K. Alpha-Internexin, a 66-kD intermediate filament-binding protein from mammalian central nervous tissues. J. Cell Biol. 1985, 101:1316-1322.
31. Paquette J.A., Kumpf S.W., Streck R.D., Thomson J.J., Chapin R.E., Stedman D.B. Assessment of the embryonic stem cell test and application and use in the pharmaceutical industry. Birth Defects Res.,Part B 2008, 83:104-111.
32. Pébay A., Wong R.C., Pitson S.M., Wolvetang E.J., Peh G.S., Filipczyk A., Koh K.L., Tellis I., Nguyen L.T., Pera M.F. Essential roles of sphingosine-1-phosphate and platelet-derived growth factor in the maintenance of human embryonic stem cells. Stem Cells 2005, 23:1541-1548.
33. Riebeling, C., Pirow, R., Becker, K., Buesen, R., Eikel, D., Kaltenhäuser, J., Meyer, F., Nau, H., Slawik, B., Visan, A., Volland, J., Spielmann, H., Luch, A., Seiler, A., 2011. The embryonic stem cell test as tool to assess structure-dependent teratogenicity: the case of valproic acid. Toxicol. Sci. doi:10.1093/toxsci/kfr001.
34. Rodgers K.D., San Antonio J.D., Jacenko O. Heparan sulfate proteoglycans: a GAGgle of skeletal-hematopoietic regulators. Dev. Dyn. 2008, 237:2622-2642.
35. Rodin S., Domogatskaya A., Strom S., Hansson E.M., Chien K.R., Inzunza J., Hovatta O., Tryggvason K. Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat. Biotechnol. 2010, 28:611-615.
36. Sachinidis A., Gissel C., Nierhoff D., Hippler-Altenburg R., Sauer H., Wartenberg M., Hescheler J. Identification of plateled-derived growth factor-BB as cardiogenesis-inducing factor in mouse embryonic stem cells under serum-free conditions. Cell. Physiol. Biochem. 2003, 13:423-429.
37. Schiff L.J. Review: production, characterization, and testing of banked mammalian cell substrates used to produce biological products. In Vitro Cell. Dev. Biol. Anim. 2005, 41:65-70.
38. Seiler A., Visan A., Buesen R., Genschow E., Spielmann H. Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test. Reprod. Toxicol. 2004, 18:231-240.
39. Seiler A.E., Buesen R., Visan A., Spielmann H. Use of murine embryonic stem cells in embryotoxicity assays: the embryonic stem cell test. Methods Mol. Biol. 2006, 329:371-395.
40. Shimoji K., Yuasa S., Onizuka T., Hattori F., Tanaka T., Hara M., Ohno Y., Chen H., Egasgira T., Seki T., Yae K., Koshimizu U., Ogawa S., Fukuda K. G-CSF promotes the proliferation of developing cardiomyocytes in vivo and in derivation from ESCs and iPSCs. Cell Stem Cell 2010, 6:227-237.
41. Spielmann H., Pohl I., Döring B., Liebsch M., Moldenhauer F. The Embryonic stem cell test, an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. In Vitro Mol. Toxicol. 1997, 10:119-127.
42. Stein A. Decreasing variability in your cell culture. Biotechniques 2007, 43:228-229.
43. Takahashi T., Lord B., Schulze P.C., Fryer R.M., Sarang S.S., Gullans S.R., Lee R.T. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 2003, 107:1912-1916.
44. Tischfield M.A., Baris H.N., Wu C., Rudolph G., Van M.L., He W., Chan W.M., Andrews C., Demer J.L., Robertson R.L., Mackey D.A., Ruddle J.B., Bird T.D., Gottlob I., Pieh C., Traboulsi E.I., Pomeroy S.L., Hunter D.G., Soul J.S., Newlin A., Sabol L.J., Doherty E.J., de Uzcategui C.E., de U.N., Collins M.L., Sener E.C., Wabbels B., Hellebrand H., Meitinger T., de B.T., Magli A., Schiavi C., Pastore-Trossello M., Koc F., Wong A.M., Levin A.V., Geraghty M.T., Descartes M., Flaherty M., Jamieson R.V., Moller H.U., Meuthen I., Callen D.F., Kerwin J., Lindsay S., Meindl A., Gupta M.L., Pellman D., Engle E.C. Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance. Cell 2010, 140:74-87.
45. Turksen K. Embryonic Stem Cell Protocols 2006, Humana Press, Totowa, NJ, USA.
46. Unger C., Skottman H., Blomberg P., Dilber M.S., Hovatta O. Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum. Mol. Genet. 2008, 17:R48-R53.
47. USFDA, 1993. Points to Consider in the Characterization of Cell Lines Used to Produce Biologicals. In: http://www.fda.gov/downloads/BiologicsBlood%20861Vaccines/GuidanceComplianceRegulatoryInformation/OtherRecommendations%20862forManufacturers/UCM062745.pdf.
48. van der Valk, Mellor D., Brands R., Fischer R., Gruber F., Gstraunthaler G., Hellebrekers L., Hyllner J., Jonker F.H., Prieto P., Thalen M., Baumans V. The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicol. In Vitro 2004, 18:1-12.
49. Villa-Diaz L.G., Nandivada H., Ding J., Nogueira-de-Souza N.C., Krebsbach P.H., O'Shea K.S., Lahann J., Smith G.D. Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat. Biotechnol. 2010, 28:581-583.
50. Visan A., Hayess K., Slawik B., Pohl E., Spielmann H., Luch A., Seiler A. Towards the differentiation of mouse embryonic stem cells into functional neurons for developmental neurotoxicity testing in vitro. ALTEX 2009, 26S:356.
51. Wessman S.J., Levings R.L. Benefits and risks due to animal serum used in cell culture production. Dev. Biol. Stand. 1999, 99:3-8.
52. Whitlow S., Burgin H., Clemann N. The embryonic stem cell test for the early selection of pharmaceutical compounds. ALTEX 2007, 24:3-7.
53. Wiles M.V., Johansson B.M. Embryonic stem cell development in a chemically defined medium. Exp. Cell Res. 1999, 247:241-248.
54. Wobus A.M., Wallukat G., Hescheler J. Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation 1991, 48:173-182.
55. Xu X.Q., Graichen R., Soo S.Y., Balakrishnan T., Rahmat S.N., Sieh S., Tham S.C., Freund C., Moore J., Mummery C., Colman A., Zweigerdt R., Davidson B.P. Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation 2008, 76:958-970.
56. Yao S., Chen S., Clark J., Hao E., Beattie G.M., Hayek A., Ding S. Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc. Natl. Acad. Sci. USA 2006, 103:6907-6912.
57. Ying Q.L., Smith A.G. Defined conditions for neural commitment and differentiation. Methods Enzymol. 2003, 365:327-341.
58. zur Nieden N.I., Kempka G., Ahr H.J. Molecular multiple endpoint embryonic stem cell test-a possible approach to test for the teratogenic potential of compounds. Toxicol. Appl. Pharmacol. 2004, 194:257-269.